BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 30559369)

  • 21. Whole genome sequence of first Candida auris strain, isolated in Russia.
    Pchelin IM; Azarov DV; Churina MA; Ryabinin IA; Vibornova IV; Apalko SV; Kruglov AN; Sarana AM; Taraskina AE; Vasilyeva NV
    Med Mycol; 2020 Apr; 58(3):414-416. PubMed ID: 31290551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
    Iguchi S; Itakura Y; Yoshida A; Kamada K; Mizushima R; Arai Y; Uzawa Y; Kikuchi K
    J Infect Chemother; 2019 Oct; 25(10):743-749. PubMed ID: 31257156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
    Wurster S; Bandi A; Beyda ND; Albert ND; Raman NM; Raad II; Kontoyiannis DP
    J Antimicrob Chemother; 2019 Jul; 74(7):1904-1910. PubMed ID: 31225606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen.
    Dekkerová J; Lopez-Ribot JL; Bujdáková H
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):101-108. PubMed ID: 30327897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the emergence, spread and resistance of
    Chakrabarti A; Sood P
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33599604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candida auris and Nosocomial Infection.
    Dahiya S; Chhillar AK; Sharma N; Choudhary P; Punia A; Balhara M; Kaushik K; Parmar VS
    Curr Drug Targets; 2020; 21(4):365-373. PubMed ID: 31549952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The first cases of Candida auris candidaemia in Oman.
    Mohsin J; Hagen F; Al-Balushi ZAM; de Hoog GS; Chowdhary A; Meis JF; Al-Hatmi AMS
    Mycoses; 2017 Sep; 60(9):569-575. PubMed ID: 28685887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What do we know about the biology of the emerging fungal pathogen of humans Candida auris?
    Bravo Ruiz G; Lorenz A
    Microbiol Res; 2021 Jan; 242():126621. PubMed ID: 33096325
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Warris A
    Arch Dis Child; 2018 Sep; 103(9):891-894. PubMed ID: 29545411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.
    Tsay S; Kallen A; Jackson BR; Chiller TM; Vallabhaneni S
    Clin Infect Dis; 2018 Jan; 66(2):306-311. PubMed ID: 29020224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant
    Walia K; Chowdhary A; Ohri VC; Chakrabarti A
    Indian J Med Microbiol; 2017; 35(3):436. PubMed ID: 29063895
    [No Abstract]   [Full Text] [Related]  

  • 33. Candida auris, an emerging and disturbing yeast.
    Coste AT; Imbert C; Hennequin C
    J Mycol Med; 2019 Jun; 29(2):105-106. PubMed ID: 31178041
    [No Abstract]   [Full Text] [Related]  

  • 34. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.
    Khan Z; Ahmad S; Al-Sweih N; Joseph L; Alfouzan W; Asadzadeh M
    PLoS One; 2018; 13(4):e0195743. PubMed ID: 29630658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds.
    Casadevall A; Kontoyiannis DP; Robert V
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The High-Quality Complete Genome Sequence of the Opportunistic Fungal Pathogen Candida vulturna CBS 14366
    Navarro-Muñoz JC; de Jong AW; Gerrits van den Ende B; Haas PJ; Then ER; Mohd Tap R; Collemare J; Hagen F
    Mycopathologia; 2019 Dec; 184(6):731-734. PubMed ID: 31734799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Throughput Profiling of Candida auris Isolates Reveals Clade-Specific Metabolic Differences.
    Brandt P; Mirhakkak MH; Wagner L; Driesch D; Möslinger A; Fänder P; Schäuble S; Panagiotou G; Vylkova S
    Microbiol Spectr; 2023 Jun; 11(3):e0049823. PubMed ID: 37097196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ClaID: a Rapid Method of Clade-Level Identification of the Multidrug Resistant Human Fungal Pathogen Candida auris.
    Narayanan A; Selvakumar P; Siddharthan R; Sanyal K
    Microbiol Spectr; 2022 Apr; 10(2):e0063422. PubMed ID: 35343775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Candida auris: The Recent Emergence of a Multiresistant Pathogenic Fungi].
    Antunes F; Veríssimo C; Pereira ÁA; Sabino R
    Acta Med Port; 2020 Oct; 33(10):680-684. PubMed ID: 33135623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal resistance: an emerging battlefield.
    Woo PC; Tsang CC; Lau SK
    Future Microbiol; 2020 May; 15():571-574. PubMed ID: 32484001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.